CellSource Co

CellSource Co Revenue per Employee

The Revenue per Employee of CellSource Co (4880.T) as of Oct 27, 2026 is 34.05 M JPY. In the previous year, Revenue per Employee was 39.95 M JPY — a change of -14.78% (lower).

Revenue per Employee

34.05 MJPY

YoY

-14.78%

Last updated:

Revenue per Employee of CellSource Co is 2025 34.05 M JPY. Revenue per Employee of CellSource Co was 2024 39.95 M JPY. It decreases by -14.78% lower compared to the previous year.

The CellSource Co Revenue per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Employee
Date
Revenue per Employee
Jan 1, 2018
11.13 M JPY
Jan 1, 2019
14.79 M JPY
Jan 1, 2020
17.02 M JPY
Jan 1, 2021
26.81 M JPY
Jan 1, 2022
39.21 M JPY
Jan 1, 2023
41.38 M JPY
Jan 1, 2024
39.95 M JPY
Jan 1, 2025
34.05 M JPY
The CellSource Co Revenue per Employee history
YEARRevenue per EmployeeYoY
34.05 MJPY-14.78%
39.95 MJPY-3.45%
41.38 MJPY+5.54%
39.21 MJPY+46.25%
26.81 MJPY+57.49%
17.02 MJPY+15.13%
14.79 MJPY+32.89%
11.13 MJPY+133.64%
4.76 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Revenue per Employee of CellSource Co is 34.05 M JPY in 2025.

Revenue per Employee of CellSource Co changed from 39.95 M JPY to 34.05 M JPY, representing a -14.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Employee CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Revenue per employee measures workforce productivity by dividing total revenue by the number of employees. Higher values indicate more efficient operations.

Revenue per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Revenue per Employee's CellSource Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — CellSource Co

All Key Metrics — CellSource Co